<?xml version="1.0" encoding="UTF-8"?><rss version="0.92">
<channel>
	<title>1 Boring Old Man</title>
	<link>http://1boringoldman.com</link>
	<description>All Mickey, All the Time</description>
	<lastBuildDate>Mon, 06 Feb 2012 20:03:16 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	<!-- generator="WordPress/3.0.5" -->

	<item>
		<title>wisdom in his pages&#8230;</title>
		<description><![CDATA[Dr. Healy&#8217;s Pharmageddon is one of those books to be read, not summarized. It&#8217;s not that it&#8217;s filled with new information. He sees what the rest of us see, albeit from the position more interior than most &#8211; a neuroscientist who has been embedded in the scene. He writes about the primacy of the pharmaceutical [...]]]></description>
		<link>http://1boringoldman.com/index.php/2012/02/06/wisdom-in-his-pages/</link>
			</item>
	<item>
		<title>on being a Medicine-Man&#8230;</title>
		<description><![CDATA[I wrote a post on the Era of Patent Medicines at the end of the 19th and beginning of the 20th century around this time last year [patent medicine and ambiguity&#8230;]. And while this is not my definitive comment on David Healy&#8217;s Pharmageddon, it&#8217;s his book that got me going on the topic [again]. I [...]]]></description>
		<link>http://1boringoldman.com/index.php/2012/02/05/on-being-a-medicine-man/</link>
			</item>
	<item>
		<title>none reported&#8230;</title>
		<description><![CDATA[Ten-Year Trends in Quality of Care and Spending for Depression 1996 Through 2005 by Catherine A. Fullerton, MD, MPH; Alisa B. Busch, MD, MS; Sharon-Lise T. Normand, PhD; Thomas G. McGuire, PhD; and Arnold M. Epstein, MD Archives of General Psychiatry. 2011 68:1218-1226. Context: During the past decade, the introduction of generic versions of newer [...]]]></description>
		<link>http://1boringoldman.com/index.php/2012/02/04/none-reported/</link>
			</item>
	<item>
		<title>another point [résumé churning]&#8230;</title>
		<description><![CDATA[Study 329 has been analyzed [Healthy Skepticism], the subject of a book [Side Effects: A Prosecutor, a Whistleblower, and a Bestselling Antidepressant on Trial], been discussed in a number of courtrooms, and is a topic on every blog that has ever focused on the corruption of modern psychopharmacology including this one: Efficacy of Paroxetine in [...]]]></description>
		<link>http://1boringoldman.com/index.php/2012/02/04/another-point/</link>
			</item>
	<item>
		<title>why not now?&#8230;</title>
		<description><![CDATA[U. will not support Keller retraction by Sahil Luthra February 3, 2012 &#160; The University will not support an effort to retract a controversial study co-authored by Professor of Psychiatry and Human Behavior Martin Keller, wrote Edward Wing, dean of medicine and biological sciences, in a recent letter to the global nonprofit Healthy Skepticism. The [...]]]></description>
		<link>http://1boringoldman.com/index.php/2012/02/03/why-not-now/</link>
			</item>
	<item>
		<title>for real&#8230;</title>
		<description><![CDATA[Among the stories that have emerged over the last twenty years in this age of psychopharmacology, few are as strange as the story of John Rush who was in the Department of Psychiatry at the University of Texas Southwestern for thirty years. Early on, he had studied Cognitive Behavior Therapy with Aaron Beck but not [...]]]></description>
		<link>http://1boringoldman.com/index.php/2012/02/03/i-dont-understand/</link>
			</item>
	<item>
		<title>and&#8230;</title>
		<description><![CDATA[]]></description>
		<link>http://1boringoldman.com/index.php/2012/02/03/and-10/</link>
			</item>
	<item>
		<title>let the discovery begin&#8230;</title>
		<description><![CDATA[Whistleblower Claims Forest Bribed Study&#8217;s Investigator to Favor Celexa Bloomberg By John T. Aquino February 1, 2012 A whistleblower&#8217;s complaint from 2011 that was unsealed Jan. 20 in a federal district court alleged that Forest Pharmaceuticals paid the principal investigator of a federally funded antidepressant drug study to fix the results in favor of the [...]]]></description>
		<link>http://1boringoldman.com/index.php/2012/02/02/19098/</link>
			</item>
	<item>
		<title>sooner or later&#8230;</title>
		<description><![CDATA[In response to a request from Senator Grassley, the Government Accountability Office did a survey [12/01/2011] of the medication of Medicaid covered children with psychotropic drugs in five States [Florida, Texas, Oregon, Michigan, and Massachusetts], separating Foster Children and non-Foster Children: &#160;&#160; Medicaid &#8211; Foster Children Age FL TX OR MI MA &#160; 0-5 5.3% [...]]]></description>
		<link>http://1boringoldman.com/index.php/2012/02/02/sooner-or-later/</link>
			</item>
	<item>
		<title>déjà vu again&#8230;</title>
		<description><![CDATA[&#160; The two drugs under consideration here are RISPERDAL&#174; CONSTA&#174;, an injectable version of Risperdal [monthly] approved by the FDA in 2003, and INVEGA&#174; SUSTENNA&#174;, an injectable version of PALIPERIDONE PALMITATE [9-hydroxy-risperidone] with a different delivery system approved by the FDA in 2009. Janssen has launched a campaign to help patients use their injectable drugs [...]]]></description>
		<link>http://1boringoldman.com/index.php/2012/02/02/deja-vu-again/</link>
			</item>
</channel>
</rss>

